drugset / Trial / NCT02229786

Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms

NCT02229786

Phase 2 Completed 1637 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to evaluate efficacy and tolerability of Buscopan® plus versus Buscopan®, paracetamol, and placebo in patients with painful gastric or intestinal spasms.

Timeline

Start
1998-02
Primary completion
1999-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule
Subject Buscopan® plus Unknown
Subject Hyoscine butylbromide Unknown